Subclinical hypothyroidism: an update for primary care physicians.

[1]  Haiqing Zhang,et al.  Subclinical hypothyroidism , 2009 .

[2]  M. Bissell.  Variation in Thyroid Function Tests in Patients with Stable Untreated Subclinical Hypothyroidism , 2009 .

[3]  B. Velkeniers,et al.  Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies. , 2008, European journal of endocrinology.

[4]  M. Vanderpump,et al.  The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis. , 2008, The Journal of clinical endocrinology and metabolism.

[5]  D. Bauer,et al.  Meta-analysis: Subclinical Thyroid Dysfunction and the Risk for Coronary Heart Disease and Mortality , 2008, Annals of Internal Medicine.

[6]  K. Kopecky,et al.  Thyrotropin levels in a population with no clinical, autoantibody, or ultrasonographic evidence of thyroid disease: implications for the diagnosis of subclinical hypothyroidism. , 2008, The Journal of clinical endocrinology and metabolism.

[7]  Sarabjeet Singh,et al.  Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis. , 2008, International journal of cardiology.

[8]  P. Laurberg,et al.  Variation in thyroid function tests in patients with stable untreated subclinical hypothyroidism. , 2008, Thyroid : official journal of the American Thyroid Association.

[9]  B. Biondi,et al.  The clinical significance of subclinical thyroid dysfunction. , 2008, Endocrine reviews.

[10]  M. Surks,et al.  Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. , 2007, The Journal of clinical endocrinology and metabolism.

[11]  L. Duntas,et al.  Cardiovascular risk and subclinical hypothyroidism: focus on lipids and new emerging risk factors. What is the evidence? , 2007, Thyroid : official journal of the American Thyroid Association.

[12]  L. Braverman,et al.  National Health and Nutrition Examination Survey III thyroid-stimulating hormone (TSH)-thyroperoxidase antibody relationships demonstrate that TSH upper reference limits may be skewed by occult thyroid dysfunction. , 2007, The Journal of clinical endocrinology and metabolism.

[13]  B. Biondi.  Cardiovascular effects of mild hypothyroidism. , 2007, Thyroid : official journal of the American Thyroid Association.

[14]  H. Saconato,et al.  Thyroid hormone replacement for subclinical hypothyroidism. , 2007, Cochrane Database of Systematic Reviews.

[15]  J. Weaver,et al.  The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. , 2007, The Journal of clinical endocrinology and metabolism.

[16]  G. Guyatt,et al.  Does treatment withl-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism? , 1996, Journal of General Internal Medicine.

[17]  B. Shields,et al.  Detection of thyroid dysfunction in early pregnancy: Universal screening or targeted high-risk case finding? , 2007, The Journal of clinical endocrinology and metabolism.

[18]  E. Mazzaferri.  Thyroid Status, Cardiovascular Risk, and Mortality in Older Adults , 2007 .

[19]  J. Franklyn,et al.  Is Subclinical Thyroid Dysfunction in the Elderly Associated with Depression or Cognitive Dysfunction? , 2006, Annals of Internal Medicine.

[20]  E. Vittinghoff,et al.  Subclinical hypothyroidism and the risk of coronary heart disease: a meta-analysis. , 2006, The American journal of medicine.

[21]  J. Sundsfjord,et al.  Neuropsychological function and symptoms in subjects with subclinical hypothyroidism and the effect of thyroxine treatment. , 2006, The Journal of clinical endocrinology and metabolism.

[22]  D. Ross.  Subclinical hypothyroidism : When to treat, when to watch , 2006 .

[23]  D. King,et al.  Serum biomarkers for cardiovascular inflammation in subclinical hypothyroidism , 2005, Clinical endocrinology.

[24]  M. Surks,et al.  The thyrotropin reference range should remain unchanged. , 2005, The Journal of clinical endocrinology and metabolism.

[25]  L. Wartofsky,et al.  The evidence for a narrower thyrotropin reference range is compelling. , 2005, The Journal of clinical endocrinology and metabolism.

[26]  J. Haddow,et al.  2004 where do we go from here?--Summary of working group discussions on thyroid function and gestational outcomes. , 2005, Thyroid : official journal of the American Thyroid Association.

[27]  H. Gharib,et al.  Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. , 2004, The Journal of clinical endocrinology and metabolism.

[28]  A. D. de Craen,et al.  Thyroid status, disability and cognitive function, and survival in old age. , 2004, JAMA.

[29]  P. Iglesias,et al.  Spontaneous subclinical hypothyroidism in patients older than 55 years: an analysis of natural course and risk factors for the development of overt thyroid failure. , 2004, The Journal of clinical endocrinology and metabolism.

[30]  M. Christ-Crain,et al.  Effect of l-Thyroxine Replacement Therapy on Surrogate Markers of Skeletal and Cardiac Function in Subclinical Hypothyroidism , 2004 .

[31]  J. Franklyn,et al.  Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. , 2004, JAMA.

[32]  V. Fatourechi.  Subclinical hypothyroidism: When to treat, when to watch? , 2004 .

[33]  H. Gharib,et al.  Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. , 2004, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[34]  M. Brennan,et al.  Effects of reducing the upper limit of normal TSH values. , 2003, JAMA.

[35]  D. Vanness,et al.  Factors influencing clinical decisions to initiate thyroxine therapy for patients with mildly increased serum thyrotropin (5.1-10.0 mIU/L). , 2003, Mayo Clinic proceedings.

[36]  B. Biondi,et al.  Effects of Subclinical Thyroid Dysfunction on the Heart , 2002, Annals of Internal Medicine.

[37]  C. Doré,et al.  A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism. , 2002, The American journal of medicine.

[38]  W Harry Hannon,et al.  Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). , 2002, The Journal of clinical endocrinology and metabolism.

[39]  V. Fatourechi.  Subclinical Hypothyroidism , 2002, Treatments in endocrinology.

[40]  A. McMahon,et al.  Thyroxine treatment in patients with symptoms of hypothyroidism but thyroid function tests within the reference range: randomised double blind placebo controlled crossover trial , 2001, BMJ : British Medical Journal.

[41]  J. Chu,et al.  The treatment of subclinical hypothyroidism is seldom necessary. , 2001, The Journal of clinical endocrinology and metabolism.

[42]  M. Mcdermott,et al.  Subclinical hypothyroidism is mild thyroid failure and should be treated. , 2001, The Journal of clinical endocrinology and metabolism.

[43]  J. Drewe,et al.  TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). , 2001, The Journal of clinical endocrinology and metabolism.

[44]  D. Cooper.  Clinical practice. Subclinical hypothyroidism. , 2001, The New England journal of medicine.

[45]  N. Powe,et al.  Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. , 2000, The Journal of clinical endocrinology and metabolism.

[46]  H. D. Cohen,et al.  American Thyroid Association guidelines for detection of thyroid dysfunction. , 2000, Archives of internal medicine.

[47]  G. Canaris,et al.  The Colorado thyroid disease prevalence study. , 2000, Archives of internal medicine.

[48]  A. Hofman,et al.  Subclinical Hypothyroidism Is an Independent Risk Factor for Atherosclerosis and Myocardial Infarction in Elderly Women: The Rotterdam Study , 2000, Annals of Internal Medicine.

[49]  S. Waisbren,et al.  "Maternal Thyroid Deficiency During Pregnancy and Subsequent Neuropsychological Development of the Child" (1999), by James E. Haddow et al. , 2014 .

[50]  M. Helfand,et al.  Screening for Thyroid Disease: An Update , 1998, Annals of Internal Medicine.

[51]  J. French,et al.  The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. , 2009, Thyroid : official journal of the American Thyroid Association.

[52]  J. French,et al.  The incidence of thyroid disorders in the community: a twenty‐year follow‐up of the Whickham Survey , 1995, Clinical endocrinology.

[53]  J. Haggerty,et al.  Borderline hypothyroidism and depression. , 1995, Annual review of medicine.

[54]  C. Nemeroff,et al.  Subclinical Hypothyroidism: A Review of Neuropsychiatric Aspects , 1990, International journal of psychiatry in medicine.

[55]  K. Caidahl,et al.  A DOUBLE‐BLIND CROSS‐OVER 12‐MONTH STUDY OF l‐THYROXINE TREATMENT OF WOMEN WITH ‘SUBCLINICAL’ HYPOTHYROIDISM , 1988, Clinical endocrinology.

[56]  D. Cooper,et al.  L-Thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial. , 1984, Annals of internal medicine.